TD Waterhouse Canada Inc. Boosts Holdings in GE HealthCare Technologies Inc. $GEHC

TD Waterhouse Canada Inc. raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9.5% in the 2nd quarter, Holdings Channel.com reports. The fund owned 579,138 shares of the company’s stock after acquiring an additional 50,318 shares during the quarter. TD Waterhouse Canada Inc.’s holdings in GE HealthCare Technologies were worth $37,590,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of GEHC. Banque Cantonale Vaudoise boosted its holdings in GE HealthCare Technologies by 16,539.1% in the first quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock worth $1,849,000 after acquiring an additional 25,801 shares in the last quarter. Allstate Corp grew its stake in shares of GE HealthCare Technologies by 100.3% during the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock worth $2,681,000 after acquiring an additional 16,365 shares during the last quarter. Auto Owners Insurance Co increased its holdings in shares of GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares in the last quarter. Northside Capital Management LLC increased its holdings in shares of GE HealthCare Technologies by 26.5% during the second quarter. Northside Capital Management LLC now owns 241,923 shares of the company’s stock valued at $15,485,000 after acquiring an additional 50,634 shares in the last quarter. Finally, Boston Partners raised its position in shares of GE HealthCare Technologies by 21.7% in the 4th quarter. Boston Partners now owns 4,659,562 shares of the company’s stock valued at $382,223,000 after purchasing an additional 830,626 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 1.2%

Shares of GE HealthCare Technologies stock opened at $68.86 on Friday. The stock has a market cap of $31.10 billion, a PE ratio of 15.79, a price-to-earnings-growth ratio of 1.84 and a beta of 0.70. The firm has a fifty day moving average price of $68.29 and a 200 day moving average price of $69.01. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.26 and a quick ratio of 0.97.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, beating the consensus estimate of $1.04 by $0.09. The company had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The firm’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company earned $1.06 earnings per share. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.93 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Friday, July 24th were paid a $0.035 dividend. The ex-dividend date was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.21%.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Argus lowered their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Tuesday, May 19th. Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 price target on the stock. Evercore reaffirmed an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Piper Sandler reiterated a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. Finally, BMO Capital Markets began coverage on shares of GE HealthCare Technologies in a report on Wednesday, July 8th. They set a “market perform” rating and a $70.00 price objective on the stock. Ten research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Hold” and an average price target of $77.73.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.